The incidence of early-onset colorectal cancer has increased by nearly 50 percent in the last 30 years. A University of Colorado Cancer Center study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago aimed to identify factors…
Novel Vaccine for colorectal cancer Shows Positive Phase I Results
A new colorectal cancer vaccine showed positive results in phase 1 clinical trial to demonstrate that the approach is safe. The patients treated had no signs of serious adverse events and samples of their blood contained markers of immune activation —…
A Tiny Cry for Help From Inside the Liver Could Lead to Better Treatment
But when something comes along that badly injures enough of those cells—such as a liver-damaging overdose of pain medicine—this vital work can come to a screeching halt. With few good treatment options available, more than 2,000 Americans die of Acute liver…
Stem Cell Transplants Could Ease Crohn’s Disease
Overview of the Study A new study, led by Queen Mary University of London and Barts Health NHS Trust, is exploring the potential of stem cell transplants to ease Crohn’s disease symptoms. The research is funded with £2 million from a…
Diabetes Researchers Find Switch for Fatty Liver Disease
Duke researchers have identified a key fork in the road for the way the liver metabolism deals with carbohydrates, fats, and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and prediabetes….
Artificial Pancreas is a Safe and Effective Treatment for Type 1 Diabetes
Use of an artificial pancreas is associated with better control of blood sugar levels for people with type 1 diabetes compared with standard treatment, finds a review of the available evidence published by The BMJ today. The findings show that artificial pancreas…
Una molécula misteriosa es clave para inhibir el cáncer de colon
Immunologists at St. Jude Children’s Research Hospital have discovered that a protein called NLRC3 plays a central role in inhibiting colon cells from becoming cancerous. The study, led by Thirumala-Devi Kanneganti, Ph.D., a member of the St. Jude Department of Immunology,…
Scientists use dead bacteria to kill colorectal cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells. Harvesting the Clostridium sporogenes bacteria found commonly in soil, the NTU team was able to harness the bacteria in its dead form, and its…